Yasushi Kawaguchi
Overview
Explore the profile of Yasushi Kawaguchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
312
Citations
6960
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kinoshita T, Matsuno K, Kobayashi T, Kato A, Kawaguchi Y, Yasuda J
Uirusu
. 2025 Mar;
74(2):149-152.
PMID: 40024797
No abstract available.
2.
Ishii T, Kawaguchi Y, Ishikawa O, Takemori H, Takasawa N, Kobayashi H, et al.
Mod Rheumatol
. 2024 Nov;
PMID: 39562303
Objectives: Systemic sclerosis is characterised by ischaemic skin ulcers on the fingertips, and low-energy shock wave therapy is suggested as a novel treatment for ischaemic lesions with angiogenic effects. We...
3.
Uesugi-Uchida S, Fujimoto M, Asano Y, Endo H, Goto D, Jinnin M, et al.
J Dermatol
. 2024 Sep;
51(10):1290-1297.
PMID: 39235167
As the clinical course of systemic sclerosis (SSc) varies widely, prognostic indicators have been sought to predict the outcomes of individual patients. Racial differences in SSc render it necessary to...
4.
Liu S, Maruzuru Y, Takeshima K, Koyanagi N, Kato A, Kawaguchi Y
J Virol
. 2024 Jul;
98(8):e0073724.
PMID: 39016551
Facilitates chromatin transcription (FACT) interacts with nucleosomes to promote gene transcription by regulating the dissociation and reassembly of nucleosomes downstream and upstream of RNA polymerase II (Pol II). A previous...
5.
Hirose H, Higuchi T, Takagi K, Tochimoto A, Ichimura Y, Harigai M, et al.
Int J Rheum Dis
. 2024 Jul;
27(7):e15254.
PMID: 38973340
Aim: To evaluate whether seasonal changes influence fluctuations in serum Krebs von den Lungen-6 (KL-6) levels in systemic sclerosis-related interstitial lung disease (SSc-ILD). Methods: Summer was defined as the period...
6.
Kato A, Iwasaki R, Takeshima K, Maruzuru Y, Koyanagi N, Natsume T, et al.
J Virol
. 2024 May;
98(7):e0074724.
PMID: 38819171
Although the herpes simplex virus type 1 (HSV-1) genome was thought to contain approximately 80 different protein coding sequences (CDSs), recent multi-omics analyses reported HSV-1 encodes more than 200 potential...
7.
Nobe M, Maruzuru Y, Takeshima K, Koyanagi N, Kato A, Kawaguchi Y
Microbiol Immunol
. 2024 Feb;
68(4):148-154.
PMID: 38402407
More than 100 different herpes simplex virus 1 (HSV-1) genes belong to three major classes, and their expression is coordinately regulated and sequentially ordered in a cascade. This complex HSV-1...
8.
Ishikawa Y, Tanaka N, Asano Y, Kodera M, Shirai Y, Akahoshi M, et al.
Nat Commun
. 2024 Jan;
15(1):319.
PMID: 38296975
Here we report the largest Asian genome-wide association study (GWAS) for systemic sclerosis performed to date, based on data from Japanese subjects and comprising of 1428 cases and 112,599 controls....
9.
Hirose H, Higuchi T, Takagi K, Tochimoto A, Ichimura Y, Katsumata Y, et al.
Int J Rheum Dis
. 2023 Nov;
27(1):e14978.
PMID: 37983908
Aim: To assess the usefulness of carbohydrate antigen 19-9 (CA19-9) as a biomarker for systemic sclerosis-associated interstitial lung disease (SSc-ILD), using serum samples and clinical parameters of patients with SSc....
10.
Higuchi T, Takagi K, Tochimoto A, Ichimura Y, Hirose H, Sawada T, et al.
Sci Rep
. 2023 Nov;
13(1):19378.
PMID: 37938601
Phosphodiesterase (PDE) 4 inhibitors have been reported to suppress the progression of dermal fibrosis in patients with systemic sclerosis (SSc); however, the precise mechanisms remain to be elucidated. Therefore, we...